BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 3
  • This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4397)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.
Item 
Count 
PDF443
HTML3084
Figures (1-3)410
Tables (1-3)460
 Sum=4397
Feb 1, 2004 (publication date) through Oct 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Feb 1, 2004; 10(3): 415-418
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.415
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Expression of survivin in cholangiocarcinoma (× 200, SP).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Expression of survivin in a human cholangiocarcinoma cell line. β-actin served as control. M: DL2000 marker, 1: Normal Qbc939, 2: 24 h after adding doxorubicin, 3: 48 h after adding doxorubicin.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Expression of survivin in a human cholangiocarcinoma cell line. 1 and 2: Normal Qbc939, 3: 24 h after adding doxorubicin, 4: 48 h after adding doxorubicin.
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345